ATI
ATI NYSE Aerospace & Defense Financials FY2016βFY2025
ATI's revenue rose 5.2% to $4.6 billion in fiscal 2025. Its operating margin was 14.0%, about the same as 14.0% a year earlier. Free cash flow was $334 million, up 98.5%. It paid out $470 million in dividends and buybacks, 141% of free cash flow. The diluted share count fell 3.3%.
What ATI does
No business description yet.
- Legal name
- ATI Inc.
- Fiscal year ends
- December 28, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-010140
0001018963
Revenue and margins
ATI had $4.6B of revenue in fiscal 2025, up 5.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $334M in fiscal 2025, 7.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
ATI returned $470M to shareholders in fiscal 2025, 141% of free cash flow. The diluted share count fell 3.3%.
Value ATI yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.3B and divides by 141.8M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 46.0x Β· peers 26.2x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably ATI can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $688M | $584M | $744M | $721M | $417M |
| Debt incl. finance leases | $1.7B | $1.7B | $2.1B | $1.7B | $1.7B |
| Net debt / EBITDA | 3.9x | 2.6x | 2.3x | 1.3x | 1.6x |
| Debt / equity | 2.5x | 1.6x | 1.6x | 0.9x | 1.0x |
| Interest coverage | 1.2x | 3.1x | 5.0x | 5.6x | 5.8x |
| Current ratio | 2.7x | 2.6x | 2.8x | 2.4x | 2.7x |
| Quick ratio | 1.5x | 1.3x | 1.5x | 1.3x | 1.3x |
| Total assets | $4.3B | $4.4B | $5.0B | $5.2B | $5.1B |
| Total liabilities | $3.5B | $3.3B | $3.5B | $3.3B | $3.2B |
| Shareholders' equity | $686M | $1.0B | $1.4B | $1.9B | $1.8B |
| Net debt (β = net cash) | $1.0B | $1.1B | $1.4B | $994M | $1.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$39.0M
3 insiders
Of sales under plans
99%
$38.5M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Timothy J HarrisSenior VP and CDIO | Sold plan | 9,000 | $191.82 | $1.7M | Form 4 |
| Sep 14, 2026 | Timothy J HarrisSenior VP and CDIO | Sold plan | 16,500 | $193.06 | $3.2M | Form 4 |
| Sep 8, 2026 | Timothy J HarrisSenior VP and CDIO | Sold plan | 16,500 | $207.54 | $3.4M | Form 4 |
| Sep 2, 2026 | David J MorehouseDirector | Sold | 2,485 | $201.61 | $0.5M | Form 4 |
| Aug 31, 2026 | Timothy J HarrisSenior VP and CDIO | Sold plan | 16,500 | $210.01 | $3.5M | Form 4 |
| Aug 24, 2026 | Timothy J HarrisSenior VP and CDIO | Sold plan | 16,500 | $206.92 | $3.4M | Form 4 |
| Aug 17, 2026 | Kimberly A FieldsChair, President and CEO, Director | Sold plan | 24,845 | $231.19 | $5.7M | Form 4 |
| Jul 28, 2026 | Kimberly A FieldsChair, President and CEO, Director | Sold plan | 31,757 | $190.99 | $6.1M | Form 4 |
| Jul 7, 2026 | Kimberly A FieldsChair, President and CEO, Director | Sold plan | 40,000 | $182.91 | $7.3M | Form 4 |
| Jun 24, 2026 | Kimberly A FieldsChair, President and CEO, Director | Sold plan | 3,783 | $197.21 | $0.7M | Form 4 |
| Jun 23, 2026 | Kimberly A FieldsChair, President and CEO, Director | Sold plan | 3,641 | $197.48 | $0.7M | Form 4 |
| Jun 22, 2026 | Kimberly A FieldsChair, President and CEO, Director | Sold plan | 13,269 | $202.48 | $2.7M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 7 / 9 | 6 / 9 | 9 / 9 |
| Accruals ratio | 6.9% | β0.8% | β4.1% |
| Altman Z'' | 3.34 | 3.63 | 3.93 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| ATI ATI | $21.7B | 5.2% | 14.0% | 7.3% | 16.7% | 46.0x | 9 | |
| Moog MOG-A | $11.0B | 7.0% | 11.7% | 3.3% | 11.7% | 29.0x | 7 | Compare β |
| Curtiss-Wright CW | $17.2B | 12.1% | 18.1% | 15.8% | 15.9% | 32.0x | 8 | Compare β |
| StandardAero SARO | $7.2B | 15.8% | 9.1% | 3.9% | 8.9% | 22.5x | 8 | Compare β |
| Parsons PSN | $5.3B | β5.7% | 6.6% | 6.5% | 9.8% | 23.5x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $3.1B | $3.5B | $4.0B | $4.1B | $3.0B | $2.8B | $3.8B | $4.2B | $4.4B | $4.6B |
| Gross profit | $223M | $497M | $630M | $638M | $293M | $333M | $714M | $803M | $898M | $1.0B |
| Research and development | $14.7M | $13.3M | $22.7M | $17.8M | $14.1M | $16.5M | $16.3M | $20.7M | $19.6M | $21.3M |
| Operating income | β$542M | $135M | $362M | $366M | β$1.3B | $118M | $287M | $466M | $609M | $641M |
| Interest expense | $125M | $135M | $102M | $105M | $96.1M | $97.6M | $92.1M | $92.8M | $108M | $111M |
| Pretax income | β$734M | β$86.5M | $248M | $237M | β$1.5B | $10.6M | $162M | $295M | $486M | $522M |
| Income tax | β$107M | β$6.8M | $11.0M | β$28.5M | $77.7M | $26.8M | $15.5M | β$128M | $103M | $104M |
| Net income | β$641M | β$91.9M | $222M | $253M | β$1.6B | β$38.2M | $131M | $411M | $368M | $404M |
| Diluted EPS | β$5.97 | β$0.83 | $1.61 | $1.81 | β$12.43 | β$0.30 | $0.96 | $2.81 | $2.55 | $2.85 |
| Diluted shares | 0.11B | 0.11B | 0.15B | 0.15B | 0.13B | 0.13B | 0.15B | 0.15B | 0.15B | 0.14B |
| Cash flow | ||||||||||
| Cash from operations | β$43.7M | $22.4M | $393M | $230M | $167M | $16.1M | $225M | $85.9M | $407M | $614M |
| Capital expenditure | $202M | $123M | $139M | $168M | $137M | $153M | $131M | $201M | $239M | $281M |
| Free cash flow | β$246M | β$100M | $254M | $61.9M | $30.4M | β$137M | $94.0M | β$115M | $168M | $334M |
| Depreciation and amortization | $170M | $161M | $156M | $151M | $143M | $144M | $143M | $146M | $152M | $168M |
| Stock-based compensation | β | β | β | β | $2.9M | $21.1M | $26.0M | $29.1M | $34.1M | $29.0M |
| Acquisitions | $0.0M | $0.0M | $10.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $140M | $85.2M | $260M | $470M |
| Dividends paid | $25.8M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $25.8M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $140M | $85.2M | $260M | $470M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $230M | $142M | $382M | $491M | $646M | $688M | $584M | $744M | $721M | $417M |
| Total debt | $1.8B | $1.5B | $1.5B | $1.4B | $1.6B | $1.7B | $1.7B | $2.1B | $1.7B | $1.7B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $14.5M | $46.4M | $84.6M | $78.8M | $102M | $109M | $110M |
| Current assets | $1.8B | $1.9B | $2.2B | $2.3B | $2.1B | $2.3B | $2.5B | $2.7B | $2.9B | $2.7B |
| Current liabilities | $709M | $713M | $837M | $849M | $653M | $856M | $964M | $977M | $1.2B | $1.0B |
| Inventory | $1.0B | $1.2B | $1.2B | $1.2B | $997M | $1.0B | $1.2B | $1.2B | $1.4B | $1.4B |
| Property and equipment, net | $2.5B | $2.5B | $2.5B | $2.5B | $1.5B | $1.5B | $1.5B | $1.7B | $1.8B | $1.9B |
| Total assets | $5.2B | $5.2B | $5.5B | $5.6B | $4.0B | $4.3B | $4.4B | $5.0B | $5.2B | $5.1B |
| Total liabilities | $3.7B | $3.3B | $3.5B | $3.4B | $3.4B | $3.5B | $3.3B | $3.5B | $3.3B | $3.2B |
| Shareholders' equity | $1.4B | $1.7B | $1.9B | $2.1B | $521M | $686M | $1.0B | $1.4B | $1.9B | $1.8B |
| Margins | ||||||||||
| Gross margin | 7.1% | 14.1% | 15.6% | 15.5% | 9.8% | 11.9% | 18.6% | 19.2% | 20.6% | 22.0% |
| Operating margin | β17.3% | 3.8% | 9.0% | 8.9% | β43.7% | 4.2% | 7.5% | 11.2% | 14.0% | 14.0% |
| EBITDA margin | β11.9% | 8.4% | 12.8% | 12.6% | β38.9% | 9.3% | 11.2% | 14.7% | 17.4% | 17.6% |
| Net margin | β20.5% | β2.6% | 5.5% | 6.1% | β52.7% | β1.4% | 3.4% | 9.8% | 8.4% | 8.8% |
| FCF margin | β7.8% | β2.9% | 6.3% | 1.5% | 1.0% | β4.9% | 2.5% | β2.8% | 3.9% | 7.3% |
| Returns | ||||||||||
| Return on capital | β13.1% | 3.4% | 10.9% | 11.8% | β44.4% | 3.5% | 12.6% | 18.1% | 16.4% | 16.7% |
| Return on capital employed | β11.4% | 3.0% | 7.9% | 7.8% | β31.9% | 3.5% | 8.3% | 12.5% | 15.2% | 15.8% |
| Return on equity | β37.3% | β5.9% | 12.3% | 12.7% | β120.5% | β6.3% | 15.1% | 34.0% | 22.8% | 22.1% |
| Return on assets | β11.7% | β1.8% | 4.2% | 4.5% | β32.5% | β0.9% | 3.0% | 8.7% | 7.2% | 7.8% |
| Growth | ||||||||||
| Revenue growth | β15.7% | 12.5% | 14.8% | 1.9% | β27.7% | β6.1% | 37.0% | 8.8% | 4.5% | 5.2% |
| Net income growth | β | β | β | 13.5% | β722.8% | β | β | 213.8% | β10.5% | 9.9% |
| EPS growth | β | β | β | 12.4% | β786.7% | β | β | 192.7% | β9.3% | 11.8% |
| FCF growth | β | β | β | β75.6% | β50.9% | β549.0% | β | β222.1% | β | 98.5% |
| Share count change | 0.0% | 2.6% | 32.5% | 0.4% | β13.7% | 0.5% | 19.0% | β0.8% | β2.3% | β3.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | 4.7x | 2.2x | 1.7x | β | 3.9x | 2.6x | 2.3x | 1.3x | 1.6x |
| Debt / equity | 1.3x | 0.9x | 0.8x | 0.7x | 3.0x | 2.5x | 1.6x | 1.6x | 0.9x | 1.0x |
| Interest coverage | β4.3x | 1.0x | 3.6x | 3.5x | β13.6x | 1.2x | 3.1x | 5.0x | 5.6x | 5.8x |
| Current ratio | 2.5x | 2.7x | 2.7x | 2.7x | 3.2x | 2.7x | 2.6x | 2.8x | 2.4x | 2.7x |
| Quick ratio | 1.0x | 1.0x | 1.2x | 1.4x | 1.6x | 1.5x | 1.3x | 1.5x | 1.3x | 1.3x |
| Capital allocation | ||||||||||
| Capex / revenue | 6.5% | 3.5% | 3.4% | 4.1% | 4.6% | 5.5% | 3.4% | 4.8% | 5.5% | 6.1% |
| Stock comp / revenue | β | β | β | β | 0.1% | 0.8% | 0.7% | 0.7% | 0.8% | 0.6% |
| Payouts / FCF | β | β | 0.0% | 0.0% | 0.0% | β | 148.8% | β | 154.7% | 140.9% |
| Quality scores | ||||||||||
| Piotroski F-score | 3.0 | 7.0 | 7.0 | 5.0 | 4.0 | 5.0 | 7.0 | 7.0 | 6.0 | 9.0 |
| Altman Z'' | 1.9 | 3.0 | 3.6 | 3.8 | 0.4 | 2.7 | 3.2 | 3.3 | 3.6 | 3.9 |
| Accruals ratio | β10.9% | β2.2% | β3.2% | 0.4% | β36.0% | β1.3% | β2.2% | 6.9% | β0.8% | β4.1% |
Source: SEC EDGAR XBRL filings (CIK 0001018963). Data updated October 16, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.